Company Filing History:
Years Active: 2022
Title: Colleen Garrett: Innovator in Pharmaceutical Compositions
Introduction
Colleen Garrett is a notable inventor based in Chicago, IL (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Hepatitis C Virus (HCV). Her innovative work has led to the development of a unique solid pharmaceutical composition that showcases her expertise and dedication to improving healthcare.
Latest Patents
Colleen Garrett holds 1 patent for her invention titled "Solid pharmaceutical compositions for treating HCV." This patent features solid pharmaceutical compositions comprising Compound 1 and Compound 2. In one embodiment, the solid pharmaceutical composition includes (1) a first layer which comprises 100 mg Compound 1, along with a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant, all formulated in amorphous solid dispersion; and (2) a second layer which comprises 40 mg Compound 2, also combined with a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant, all formulated in amorphous solid dispersion.
Career Highlights
Colleen Garrett is associated with AbbVie Inc., a leading biopharmaceutical company. Her role at AbbVie has allowed her to work on groundbreaking research and development projects that aim to enhance treatment options for patients suffering from HCV. Her dedication to innovation in pharmaceuticals has positioned her as a key player in the industry.
Collaborations
Colleen has collaborated with esteemed colleagues such as Nancy E Sever and Ulrich Westedt. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
Colleen Garrett's contributions to the field of pharmaceuticals, particularly through her patent for solid pharmaceutical compositions for treating HCV, highlight her innovative spirit and commitment to improving patient outcomes. Her work at AbbVie Inc. and collaborations with other professionals further emphasize her impact on the industry.